Tech Company Financing Transactions

Anacor Pharmaceuticals Funding Round

On 1/6/2009, Anacor Pharmaceuticals raised $50 million in funding from Aberdare Ventures, Care Capital and GlaxoSmithKline.

Transaction Overview

Announced On
1/6/2009
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors

Aberdare Ventures (Paul Klingenstein)

Care Capital

GlaxoSmithKline

Rho Ventures (Stephen Benkovic)

Venrock (Anders Hove)

Proceeds Purpose
Proceeds from the financing will be used to further develop Anacor's product pipeline based on its boron chemistry platform.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1020 East Meadow Cir.
Palo Alto, CA 94303
USA
Email Address
Overview
Anacor Pharmaceutical is a biopharmaceutical company developing small-molecule therapeutics from its boron chemistry platform.
Profile
Anacor Pharmaceuticals LinkedIn Company Profile
Social Media
Anacor Pharmaceuticals Company Twitter Account
Company News
Anacor Pharmaceuticals News
Facebook
Anacor Pharmaceuticals on Facebook
YouTube
Anacor Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Paul Berns
  Paul Berns LinkedIn Profile  Paul Berns Twitter Account  Paul Berns News  Paul Berns on Facebook
Chief Financial Officer
Geoffrey Parker
  Geoffrey Parker LinkedIn Profile  Geoffrey Parker Twitter Account  Geoffrey Parker News  Geoffrey Parker on Facebook
Chief Medical Officer
Lee Zane
  Lee Zane LinkedIn Profile  Lee Zane Twitter Account  Lee Zane News  Lee Zane on Facebook
VP - Bus. Development
Erik Wiberg
  Erik Wiberg LinkedIn Profile  Erik Wiberg Twitter Account  Erik Wiberg News  Erik Wiberg on Facebook
VP - Finance
James Marconi
  James Marconi LinkedIn Profile  James Marconi Twitter Account  James Marconi News  James Marconi on Facebook
VP - General Counsel
Ryan Sullivan
  Ryan Sullivan LinkedIn Profile  Ryan Sullivan Twitter Account  Ryan Sullivan News  Ryan Sullivan on Facebook
VP - Product Management
Kirk Maples
  Kirk Maples LinkedIn Profile  Kirk Maples Twitter Account  Kirk Maples News  Kirk Maples on Facebook
VP - R & D
Jacob Plattner
  Jacob Plattner LinkedIn Profile  Jacob Plattner Twitter Account  Jacob Plattner News  Jacob Plattner on Facebook
VP - Regulatory Affairs
Carmen Rodriguez
  Carmen Rodriguez LinkedIn Profile  Carmen Rodriguez Twitter Account  Carmen Rodriguez News  Carmen Rodriguez on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/6/2009: RipCode venture capital transaction
Next: 1/6/2009: Entra Pharmaceuticals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary